We bring you the latest news from the healthcare about the health care in the United Kingdom.

zaterdag 21 oktober 2017

The Lancet: [Correspondence] Junior hospital doctors—time to rethink the terminology

[Correspondence] Junior hospital doctors—time to rethink the terminology
The moment to abandon the terms junior and trainee, as applied to hospital doctors in the National Health Service (NHS), has surely come. The labels are discriminatory, belittling, untruthful in their application, and harmful to morale. Junior is misunderstood by the public and detrimental to confidence in the service, and trainee is demeaning and suggestive of incompetence and inferiority of status. We need appropriate terms to reflect the seniority and skills of this valued cadre of doctors.
Read more

[Comment] Towards a healthier and safer environment
The Lancet Commission on pollution and health by Philip Landrigan and colleagues1 is an immensely important piece of work highlighting the impact that environmental pollution has on death and disease and the related need to scale up political will if we are to effectively confront this issue.
Read more

[Comment] Pollution, health, and the planet: time for decisive action
For decades, pollution and its harmful effects on people's health, the environment, and the planet have been neglected both by governments and the international development community. Pollution is the largest environmental cause of disease and death in the world today, responsible for an estimated 9 million premature deaths in 2015.1 92% of all pollution-related mortality is seen in low-income and middle-income countries.1 A new Lancet Commission on pollution and health aims to confront and overturn this urgent predicament.
Read more

[Perspectives] Mathuros Ruchirawat: leading light in pollution control
By the time she was in high school, Mathuros Ruchirawat had already figured out her professional calling. "I'm a scientist at heart", says Ruchirawat, now Professor of Pharmacology and Toxicology at Mahidol University in Thailand and Vice President of Research and Academic Affairs at the Chulabhorn Research Institute (CRI) where she oversees nine research laboratories. Somehow she also finds time to direct a major research and educational enterprise at Thailand's Center of Excellence on Environmental Health and Toxicology (EHT).
Read more

[Articles] PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group
The favourable outcome of patients treated with eBEACOPP could not be improved by adding rituximab after positive PET-2. PET-2 negativity allows reduction to only four cycles of eBEACOPP without loss of tumour control. PET-2-guided eBEACOPP provides outstanding efficacy for all patients and increases overall survival by reducing treatment-related risks for patients with negative PET-2. We recommend this PET-2-guided treatment strategy for patients with advanced-stage Hodgkin's lymphoma.
Read more